The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR alpha-mAb treatment in rheumatoid arthritis patients

J. Mortensen, X. Guo, M. De Los Reyes, M. Dziegiel, M. Karsdal, A. Bay-Jensen, W. White

7 Citations (Scopus)
Original languageEnglish
JournalClinical and Experimental Rheumatology
Volume37
Issue number1
ISSN0392-856X
Publication statusPublished - 2019

Keywords

  • macrophages
  • biomarker
  • citrullination
  • vimentin
  • rheumatoid arthritis
  • autoimmunity
  • anti-GM-CSF
  • matrix metalloproteinase

Fingerprint

Dive into the research topics of 'The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR alpha-mAb treatment in rheumatoid arthritis patients'. Together they form a unique fingerprint.

Cite this